PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

miR-200a Attenuated Doxorubicin-Induced Cardiotoxicity through Upregulation of Nrf2 in Mice.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31781322 ↗2019Reported benefit

miR-200a Attenuated Doxorubicin-Induced Cardiotoxicity through Upregulation of Nrf2 in Mice.

MouseChemical/toxinC57BL/6JMalen = Echocardiography in six mice per group; n = 10 per group fo…Tail vein injection for AAV9 delivery; intramyocardial injection into the left ventricle for the adenoviral Nrf2 shRNAPre-treatment: AAV9-miR-200a given 4 weeks before doxorubicin challenge

Model: Doxorubicin-induced cardiotoxicity; acute model using a single intraperitoneal injection of DOX-HCl at 15 mg/kg and chronic model using intraperitoneal DOX at 5 mg/kg weekly for four injections (cumulative dose 20 mg/kg)

miR-200a was decreased in doxorubicin-treated hearts. AAV9-mediated miR-200a overexpression restored cardiac miR-200a, blunted body weight loss, prevented the rise in cTnI and NT-proBNP, and preserved +dP/dt, ejection fraction and cardiac output after acute doxorubicin. It preserved the GSH/GSSG ra…

Extraction: extract · Supplied extraction confidence: 0.88. Machine-extracted fields require source verification.